As per GPI’s PR report, Faran Chemistry, a renowned pharmaceutical company within the Golrang pharmaceutical holding, proudly participated in the 3rd Comprehensive Gastroenterology and Liver Congress and the 10th International Hepatitis Congress (THC) in Iran. The event took place from June 19th to 24th, 2024, at the Razi International Convention Center of Iran University of Medical Sciences.
Organized by the Iranian Association for the Study of Liver Diseases and the Iranian Gastroenterology Endoscopy Association, this congress aimed to facilitate discussions and knowledge exchange on the latest advancements, techniques, and treatments related to gastrointestinal and liver diseases. It brought together distinguished national and international experts who shared their valuable insights and research findings.
Faran Chemistry actively contributed to the congress by presenting its experiences and research in gastrointestinal disease treatment. The company also showcased its therapeutic product portfolio, including medications such as Riflaxin, Hyoscine, Asfa, and the herbal supplement Octaherbalsleeper Elm.
This congress provided Faran Chemistry with an excellent opportunity to share its latest achievements in gastrointestinal and liver disease treatment with the medical community and enthusiasts. It also allowed the company to engage in meaningful discussions with specialists in the field.
